Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis.

Related Articles

Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis.

J Bone Jt Infect. 2019;4(5):234-237

Authors: Azamgarhi T, Donaldson J, Shah A, Warren S

Abstract
We report a case of an infected massive endoprosthetic replacement treated successfully with 2 stage surgery and off-label dalbavancin. Dalbavancin was used due to a limited number of antimicrobial options that could be administered safely in an outpatient setting and to avoid the need for daily dosing.

PMID: 31700772 [PubMed]